Intraoperative ultrasound guidance for palpable breast cancer excision (COBALT trial): a multicentre, randomised controlled trial

被引:149
|
作者
Krekel, Nicole M. A. [1 ]
Haloua, Max H. [1 ]
Cardozo, Alexander M. F. Lopes [4 ]
de Wit, Roos H. [4 ]
Bosch, Anne Marie [5 ]
de Widt-Levert, Louise M. [6 ]
Muller, Sandra [7 ]
van der Veen, Henk [7 ]
Bergers, Elisabeth [2 ]
de Klerk, Elly S. M. de Lange [3 ]
Meijer, Sybren [1 ]
van den Tol, M. Petrousjka [1 ]
机构
[1] Vrije Univ Amsterdam, Med Ctr, Dept Surg Oncol, NL-1081 HV Amsterdam, Netherlands
[2] Vrije Univ Amsterdam, Med Ctr, Dept Radiol, NL-1081 HV Amsterdam, Netherlands
[3] Vrije Univ Amsterdam, Med Ctr, Dept Epidemiol & Biostat, NL-1081 HV Amsterdam, Netherlands
[4] Med Ctr Alkmaar, Dept Surg, Alkmaar, Netherlands
[5] Gelderse Vallei Hosp, Dept Surg, Ede, Netherlands
[6] Waterland Hosp, Dept Surg, Purmerend, Netherlands
[7] Red Cross Hosp, Dept Surg, Beverwijk, Netherlands
来源
LANCET ONCOLOGY | 2013年 / 14卷 / 01期
关键词
CONSERVING SURGERY; SURGICAL MARGINS; GUIDED LUMPECTOMY; NEEDLE LOCALIZATION; CONSERVATION; CARCINOMA; THERAPY; FEASIBILITY; GUIDELINES; RESECTION;
D O I
10.1016/S1470-2045(12)70527-2
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background Breast-conserving surgery for palpable breast cancer is associated with tumour-involved margins in up to 41% of cases and excessively large excision volumes. Ultrasound-guided surgery has the potential to resolve both of these problems, thereby improving surgical accuracy for palpable breast cancer. We aimed to compare ultrasound-guided surgery with the standard for palpable breast cancer-palpation-guided surgery-with respect to margin status and extent of healthy breast tissue resection. Methods In this randomised controlled trial, patients with palpable T1-T2 invasive breast cancer were recruited from six medical centres in the Netherlands between October, 2010, and March, 2012. Eligible participants were randomly assigned to either ultrasound-guided surgery or palpation-guided surgery in a 1:1 ratio via a computer-generated random sequence and were stratified by study centre. Patients and investigators were aware of treatment assignments. Primary outcomes were surgical margin involvement, need for additional treatment, and excess healthy tissue resection (defined with a calculated resection ratio derived from excision volume and tumour diameter). Data were analysed by intention to treat. This trial is registered at http://www.TrialRegister.nl, number NTR2579. Findings 134 patients were eligible for random allocation. Two (3%) of 65 patients allocated ultrasound-guided surgery had tumour-involved margins compared with 12 (17%) of 69 who were assigned palpation-guided surgery (difference 14%, 95% CI 4-25; p=0.0093). Seven (11%) patients who received ultrasound-guided surgery and 19 (28%) of those who received palpation-guided surgery required additional treatment (17%, 3-30; p=0.015). Ultrasound-guided surgery also resulted in smaller excision volumes (38 [SD 26] vs 57 [41] cm(3); difference 19 cm 3, 95% CI 7-31; p=0.002) and a reduced calculated resection ratio (1.0 [SD 0.5] vs 1.7 [1.2]; difference 0.7, 95% CI 0.4-1.0; p=0.0001) compared with palpation-guided surgery. Interpretation Compared with palpation-guided surgery, ultrasound-guided surgery can significantly lower the proportion of tumour-involved resection margins, thus reducing the need for re-excision, mastectomy, and radiotherapy boost. By achieving optimum resection volumes, ultrasound-guided surgery reduces unnecessary resection of healthy breast tissue and could contribute to improved cosmetic results and quality of life. Funding Dutch Pink Ribbon Foundation, Osinga-Kluis Foundation, Toshiba Medical Systems.
引用
收藏
页码:48 / 54
页数:7
相关论文
共 50 条
  • [31] Efficacy of 'radioguided occult lesion localisation' (ROLL) versus 'wire-guided localisation' (WGL) in breast conserving surgery for non-palpable breast cancer: a randomised controlled multicentre trial
    Postma, E. L.
    Verkooijen, H. M.
    van Esser, S.
    Hobbelink, M. G.
    van der Schelling, G. P.
    Koelemij, R.
    Witkamp, A. J.
    Contant, C.
    van Diest, P. J.
    Willems, S. M.
    Rinkes, I. H. M. Borel
    van den Bosch, M. A. A. J.
    Mali, W. P.
    van Hillegersberg, R.
    BREAST CANCER RESEARCH AND TREATMENT, 2012, 136 (02) : 469 - 478
  • [32] Intraoperative ultrasound in breast cancer surgery-from localization of non-palpable tumors to objectively measurable excision
    Colakovic, Natasa
    Zdravkovic, Darko
    Skuric, Zlatko
    Mrda, Davor
    Gacic, Jasna
    Ivanovic, Nebojsa
    WORLD JOURNAL OF SURGICAL ONCOLOGY, 2018, 16
  • [33] Intraoperative ultrasound localization (IOUS) for non-palpable breast cancer
    Zahed, Shideh Pour
    Andersen, Thor Knudsen
    CANCER RESEARCH, 2020, 80 (04)
  • [34] Does the use of an Intraoperative device to assess margins reduce need for reexcison after breast conserving surgery: Multicentre Randomised Controlled Trial
    Bundred, N.
    Dixon, M.
    Acuthan, R.
    Barrett, E.
    Benson, J.
    Courtney, C. A.
    Skene, A.
    Hoar, F.
    Bhaskar, P.
    Todd, C.
    Macmillan, D.
    Watterston, D.
    Barnes, N.
    EUROPEAN JOURNAL OF CANCER, 2022, 175 : S5 - S5
  • [35] Reduction of breast lymphoedema secondary to breast cancer: a randomised controlled exercise trial
    S. L. Kilbreath
    L. C. Ward
    G. M. Davis
    A. C. Degnim
    D. A. Hackett
    T. L. Skinner
    D. Black
    Breast Cancer Research and Treatment, 2020, 184 : 459 - 467
  • [36] Reduction of breast lymphoedema secondary to breast cancer: a randomised controlled exercise trial
    Kilbreath, S. L.
    Ward, L. C.
    Davis, G. M.
    Degnim, A. C.
    Hackett, D. A.
    Skinner, T. L.
    Black, D.
    BREAST CANCER RESEARCH AND TREATMENT, 2020, 184 (02) : 459 - 467
  • [37] Intraoperative ultrasound-guided breast conserving surgery for palpable and nonpalpable breast cancer
    Cakmak, Guldeniz Karadeniz
    Emre, Ali U.
    Tascilar, Oge
    Bahadir, Burak
    Ozkan, Selcuk
    CANCER RESEARCH, 2015, 75
  • [38] Using polygenic risk modification to improve breast cancer prevention: study protocol for the PRiMo multicentre randomised controlled trial
    McInerny, Simone
    Mascarenhas, Lyon
    Yanes, Tatiane
    Petelin, Lara
    Chenevix-Trench, Georgia
    Southey, Melissa C.
    Young, Mary-Anne
    James, Paul A.
    BMJ OPEN, 2024, 14 (08):
  • [39] Therapeutic alliance in a stepped digital psychosocial intervention for breast cancer patients: findings from a multicentre randomised controlled trial
    Flix-Valle, Aida
    Medina, Joan Carles
    Souto-Sampera, Arnau
    Arizu-Onassis, Alejandra
    Juan-Linares, Eva
    Serra-Blasco, Maria
    Ciria-Suarez, Laura
    Feixas, Guillem
    Ochoa-Arnedo, Cristian
    BJPSYCH OPEN, 2025, 11 (01):
  • [40] Adjuvant denosumab in early breast cancer (D-CARE): an international, multicentre, randomised, controlled, phase 3 trial
    Coleman, Robert
    Finkelstein, Dianne M.
    Barrios, Carlos
    Martin, Miguel
    Iwata, Hiroji
    Hegg, Roberto
    Glaspy, John
    Montano Perianez, Alvaro
    Tonkin, Katia
    Deleu, Ines
    Sohn, Joohyuk
    Crown, John
    Delaloge, Suzette
    Dai, Tian
    Zhou, Ying
    Jandial, Danielle
    Chan, Arlene
    LANCET ONCOLOGY, 2020, 21 (01): : 60 - 72